N/A N=150 Risk Identification of the GlucoTab System in Routine Use
Diabetes Mellitus
Primary: Efficacy: Blood Glucose During Hospital Stay, an Expected Average of 1 Week — 159 mg/dl
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=541 Assessment of Acute Disease to Reduce Imaging Costs
Acute Coronary Syndrome · Pulmonary Embolism
Primary: Efficiency--Mean Cost of Care — 3933; 2761 US Dollars
N/A N=1,071 BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity
Breast Cancer
Primary: Number of Eligible Women Who Received Breast Cancer Risk Assessment — 8; 56; 29 Participants
N/A N=101 Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:
Rheumatoid Arthritis · Cardiovascular Diseases · Hyperlipidemias
Primary: Number of Subjects With Lipids Checked (Available Now Through National Laboratory Chain) or That Reported Having Their Lipids Checked by Their 1-week or 3-month Visit…
N/A N=25 Qualitative Assessment of Implementing Routine Rapid HIV Testing
HIV Infections
Primary: Number of Participants Who Completed the Survey — 25 participants
N/A N=982 ARgentinean Risk Assessment Registry in ACS; the ARRA-RACS Study
Chest Pain · Coronary Artery Disease · Unstable Angina Pectoris
Primary: Total Mortality. — 173 participants
N/A N=352 Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening
Colorectal Cancer
Primary: Concordance Between Patient Preference and Test Ordered — 148; 147 Participants — p=0.40
N/A N=862 The Healthcare Evaluation of Absolute Risk Testing Study
Cardiovascular Diseases
Primary: Feasibility: Count of Participants Who Were Successfully Returned a Result — 832 Participants
N/A N=451 Randomized Controlled Trial of a Risk Reframing Tool to Change Mothers' Parenting Associated With Children's Risky Play
Risk Assessment · Parenting
Primary: Change in Tolerance of Risk in Play Scale (TRiPS) — 0.05; -0.14; 0.18; -0.09 score on a scale
N/A N=112 Resident Supervision Index: Assessing Feasibility and Validity
Healthy
Primary: Intraclass Correlation Coefficient Between Physician Resident and Attending Physician. — .69 Intraclass Correlation Coefficient
N/A N=111 Social Workers Addressing Firearm Risk
Gun Violence Prevention
Primary: Change in Knowledge About Gun Violence — 2.49; 2.54; 2.94; 2.66 score on a scale
Phase 4 N=736 A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects
Rheumatoid Arthritis
Primary: Response at Week 12 as Assessed by Randomized Tool [Clinical Disease Activity Index (CDAI) or Routine Assessment of Patient Index Data 3 (RAPID3)] — 64.7; 76.4; 35.3…
N/A N=77 A Personalized Dashboard to Educate Veterans at Risk of Stroke
Cardiovascular Disease · Stroke
Primary: Change in Percentage of Participants Who Initiate Conversation With Primary Care Provider About Vascular Risk — 11.1; -21.4 percentage of patients
N/A N=1,635 Breast Cancer Risk Reduction: A Patient Doctor Intervention
Breast Cancer
Primary: Knowledge of Breast Cancer Risk Factors — 48.9; 56.4 units on a scale
N/A N=60 Incorporating CV Risk Assessment in AYA Visits
Cardiovascular Diseases
Primary: #HerHEART Risk Score in AYA From Baseline — 0.10; 0.08 Percentage Risk
N/A N=968 Intention to Prescribe/Take OAC Depending on the Number of Risk Diagrams , and Period for the Estimation of the Risk.
Atrial Fibrillation · Stroke
Primary: Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the Number of Decision Aid Diagrams — 400; 406 participants — p=0.83
N/A N=166 Risk Communication in African American Smokers
Lung Cancer
Primary: Motivation to Quit Smoking — 4.95; 3.30; 5.49; 4.52 units on a scale
N/A N=1,007 Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.
Chemotherapy-induced Febrile Neutropenia
Primary: Percentage of Investigators Who Ranked Age and Chemotherapy Regimen as a Risk Factor for Febrile Neutropenia — 73.4; 88.3; 41.1; 25.0 percentage of investigators
N/A N=279 Facilitating Assessment of At-Risk Sailors Using Technology
Psychological Distress
Primary: Percentage of Cogito Participants Reported Being Satisfied — 52 percentage of participants
N/A N=138 Adaptive Implementation Intervention for VA Suicide Risk Identification Strategy
Suicide
Primary: Change in Columbia Suicide Severity Rating Scale Screener (C-SSRS) Uptake- Phase 1 — 13.0; 11.9 change in percent adherence — p=0.18
N/A N=104,219 Cardiovascular Disease Population Risk Tool
Cardiovascular Diseases
Primary: Major Cardiovascular Disease Event — 3182; 527 Cardiovascular disease event
N/A N=304 Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users
HIV · Opioid Dependence
Primary: Demonstrated Drug Risk Reduction Skills (0-100%) — 40.60; 42.75 Percentage of correct steps
N/A N=16 Assessing Ventilator Safety in Patients on Pressure-Support Ventilation
Acute Respiratory Failure · Mechanical Ventilation Complication · Ventilator-Induced Lung Injury
Primary: Respiratory System Driving Pressure Measure by Servo Ventilator (DPrs-servo) — 12.3 centimeters of water
N/A N=1,748 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA
Acute Coronary Syndrome
Primary: All-cause Death or Subsequent Non-fatal Type 1 or Type 4b MI at One Year Measured as Time to First Such Event. — 51; 53 Participants
N/A N=101,437 Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients
Asthma
Primary: Mean Ratio of Controller Medication to Total Asthma Medication — 0.57; 0.66; 0.66; 0.71 ratio
N/A N=1,464 Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool
Opioid Abuse · Prescription Drug Abuse (Not Dependent)
Primary: Validity of the PDMP Narcotic Score Versus the WHO ASSIST — .70; .74 probability
N/A N=733 Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer
Adult Solid Neoplasm · Toxicity · Lymphoma
Primary: Patient Experienced Any Grade 3-5 Toxicity — 0.51; 0.71 proportion of participants — p=0.0001
N/A N=3,666 Impact on Management of the HEART Risk Score in Chest Pain Patients
Chest Pain
Primary: MACE (Major Adverse Cardiac Events) — 405; 345 Participants
N/A N=238 Personalized Risk Estimator for Rheumatoid Arthritis Family Study
First Degree Relatives of Rheumatoid Arthritis Patients
Primary: Contemplation Ladder — 40; 46; 43; 41 Participants — p=0.043
N/A N=172 Systematic Multi-domain Alzheimer's Risk Reduction Trial
Dementia · Alzheimer Disease
Primary: Cognitive Change — 0.34; 0.19 z-score — p=0.008